BP000061-CYT-571: Recombinant Human Beta-Defensin 2 (BD-2) Protein
Source: E. coli-derived.
The specific activity is determined by the ability to chemoattract human dendritic immature cells at a concentration of 10-100 ug/ml.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000062-CYT-036: Recombinant Mouse Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
The specific ativity is measured by its antimicrobial activity against E. coli. The ED50 for this effect is typically 4-20 ug/ml, corresponding to a specific activity of 50,000-250,000 units/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000062-CYT-063: Recombinant Rat Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
The specific ativity is measured by its antimicrobial activity against E. coli. The ED50 for this effect is typically 4-20 ug/ml, corresponding to a specific activity of 50,000-250,000 units/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000062-CYT-461: Recombinant Human Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000063-CYT-066: Recombinant Rat Beta Defensin-4 (BD-4) Protein
Source: E. coli-derived.
The specific activity is measured by its antimicrobial activity against E. coli. The ED50 for this effect is typically 5-50 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000063-CYT-599: Recombinant Human Beta Defensin-4 (BD-4) Protein
Source: E. coli-derived.
The activity is determined by its ability to chemoattract human monocytes using a concentration range of 0.1-50 ug/ml.
Purity: > 98% by SDS-PAGE and RP-HPLC.